Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues
Premiums	$ 11,436	$ 10,998	$ 34,493	$ 33,062
Net investment income	85	321	696	876
TOTAL REVENUES	63,694	49,048	181,472	144,151
Benefits and expenses
Pharmacy and other service costs	47,565	33,639	133,488	98,540
Medical costs and other benefit expenses	9,527	8,927	28,482	27,007
Selling, general and administrative expenses	3,590	3,788	10,979	10,760
Amortization of acquired intangible assets	436	454	1,279	1,368
TOTAL BENEFITS AND EXPENSES	61,118	46,808	174,228	137,675
Income from operations	2,576	2,240	7,244	6,476
Interest expense and other	(376)	(365)	(1,073)	(1,086)
Loss on sale of businesses	(87)	(21)	(106)	(21)
Net realized investment losses	(921)	(14)	(2,805)	(44)
Income before income taxes	1,192	1,840	3,260	5,325
TOTAL INCOME TAXES	367	391	1,018	1,060
Net income	825	1,449	2,242	4,265
Less: Net income attributable to noncontrolling interests	86	41	232	130
SHAREHOLDERS’ NET INCOME	$ 739	$ 1,408	$ 2,010	$ 4,135
Shareholders' net income per share
Basic (in dollars per share)	$ 2.65	$ 4.79	$ 7.13	$ 14.03
Diluted (in dollars per share)	$ 2.63	$ 4.74	$ 7.05	$ 13.89
Pharmacy revenues
Revenues
Revenue from contract with customer	$ 48,284	$ 34,531	$ 135,421	$ 100,639
Fees and other revenues
Revenues
Revenue from contract with customer	$ 3,889	$ 3,198	$ 10,862	$ 9,574